News
![](/application/files/cache/474ab2157cc64f6c5807c2ce89885687.jpg)
Amzell, B.V., a specialty pharmaceutical development company based in The Netherlands, and Amring Pharmaceuticals Inc. (Amring),…
![](/application/files/cache/474ab2157cc64f6c5807c2ce89885687.jpg)
Specialist development pharmaceutical company AMZELL B.V. and the FDA have reached an agreement on the protocol for the Phase 3 …
![](/application/files/cache/53d35027323dd283f2fd7d84ca28e10c.jpg)
Specialist pharmaceutical development company Amzell B.V has acquired Bazell Pharma AG, a high-end clinical development and R&D …
![](/application/files/cache/327a89d7f7e1a0aaefe947b5011fae23.jpg)
The specialist pharmaceutical development company, Amzell BV has appointed Dr Alan Harris, as Chairman and former Chief Scientif…